{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-061796","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.228976+00:00","generated_at":"2026-06-25T11:56:35.814670+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"VYNE hosts KOL event to update on BET inhibitor platform and VYN201","bullets":["Virtual KOL event held May 17, 2022 on InhiBET platform and VYN201.","Presentation attached as Exhibit 99.1 and available on company website.","No specific clinical data or financial results disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-061796","json":"https://secwatch.observer/filing/0001104659-22-061796.json","markdown":"https://secwatch.observer/filing/0001104659-22-061796.md","text":"https://secwatch.observer/filing/0001104659-22-061796.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/0001104659-22-061796-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/tm2215701d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T11:56:35.814670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}